Donna L. Romero
Rapt Therapeutics (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Chemical Synthesis and Analysis, HIV/AIDS Research and Interventions, DNA and Nucleic Acid Chemistry
Most-Cited Works
- → Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field(2015)1,348 cited
- → Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives(2000)377 cited
- → Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.(1991)242 cited
- → The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase(1993)162 cited
- → Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-88204E(1993)159 cited
- → Pd-Catalyzed Cycloisomerization to 1,2-Dialkylidenecycloalkanes. 2. Alternative Catalyst System(1994)155 cited
- → Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy(2015)155 cited
- → U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication(1993)143 cited
- → Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogs and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)carbonyl]-4-[3-[(1-methylethyl)amino]pyridinyl]piperazinemonomethanesulfonate (U-90152S), a second-generation clinical candidate(1993)123 cited
- → Structures, functions and adaptations of the human LINE-1 ORF2 protein(2023)113 cited